- Aclaris enters underwriting agreement for common stock and pre-funded warrants priced at $3.50 per share.
- Bookrunners include Leerink Partners, Piper Sandler, and Cantor Fitzgerald.
- Transaction results in dilution for existing shareholders.
?? Negative AI Sentiment (-4.0 / 10)